Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure
2011

HIV-1 Episomes and Viral Rebound

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Mark Sharkey, Dunja Z. Babic, Thomas Greenough, Roy Gulick, Daniel R. Kuritzkes, Mario Stevenson

Primary Institution: University of Massachusetts Medical School

Hypothesis

Can analysis of episomal HIV-1 genomes help characterize the virus that persists during antiretroviral therapy and contributes to treatment failure?

Conclusion

The study found that viral rebound after treatment interruption originated from a cryptic viral reservoir identified by episomal sequences.

Supporting Evidence

  • Episomal envelope sequences were highly similar to sequences in rebounding virus.
  • Viral rebound was linked to a cryptic viral reservoir.
  • Episomal sequences predicted treatment failure in patients receiving CCR5 antagonists.

Takeaway

This study shows that even when HIV treatment seems to be working, the virus can hide and come back when treatment stops, and we can find clues about this hidden virus by looking at special pieces of its genetic material.

Methodology

The study analyzed episomal and proviral HIV-1 genomes from six individuals who had suppressed viral replication for at least 20 months before treatment interruption.

Limitations

The study was limited to a small sample size and may not be generalizable to all HIV-1 infected individuals.

Participant Demographics

Participants were HIV-1 infected individuals on antiretroviral therapy.

Digital Object Identifier (DOI)

10.1371/journal.ppat.1001303

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication